A Phase 3 Study of CG0070 in Patients with Non-Muscular Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus CalmetteGuerin (BCG)

Administered By

Awarded By

Contributors

Start/End

  • September 20, 2021 - June 30, 2031